Tychon

Manufacturing · Minnesota, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

1015 Glenwood Ave Fl 4, Minneapolis, Min...

Phone Number

(612) 200-1039

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Tychon

Tychon Biosciences is focused on advancing precision cancer immunotherapy through its innovative PAR-T technology, which trains patients' immune cells to target and eliminate cancer cells. Their flagship product, TYC201, is a protein-based drug designed to activate T-cells for cancer treatment, offering a safer, faster, and more cost-effective solution. The therapy can be utilized as a standalone treatment or in conjunction with other therapies, making it suitable for both early and late-stage cancers. Tychon aims to enhance clinical adoption of T-cell based immunotherapy by addressing existing shortcomings in the field.Explore more
Tychon's Social MediaPopular SearchesTychonTYCHON BIOSCIENCE IncTychon Biosciences LLCTychon Bioscience LLCTychon BiosciencesSIC Code 28,283NAICS Code 32,325Show more

Tychon Org Chart

DC
United States flag for contact location.

Chief Executive Officer

PhoneEmail
CW
United States flag for contact location.

Chief Scientific Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Tychon your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Tychon

Compare insights from companies similar to Tychon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Tychon

<$5M
1-10
Private
-
2011
$29.6M
11-50
Public
<$5M
2016
TG
Trisha GoswaniChief Medical Officer
<$5M
1-10
Private
-
2012
N/A
<$5M
1-10
Private
$5.6M
2009
JJ
Jeff JudsonVice President, Strategic Planning
<$5M
1-10
Private
-
2018
<$5M
11-50
Private
$30M
2016
Deyaa Adib, Chief Medical Officer at Affyimmune Therapeutics
Deyaa AdibChief Medical Officer
<$5M
1-10
Private
<$5M
2018
SY
Susan YonemuraDirector, Product Development
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Tychon is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Tychon is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Tychon.

Tychon Tech Stack

Top Manufacturing Companies

Frequently Asked Questions Regarding Tychon

What is Tychon's official website?
Tychon's official website is www.tychonbio.com
What is Tychon's Revenue?
Tychon's revenue is <$5 Million
What is Tychon's SIC code?
Tychon's SIC: 28,283
What is Tychon's NAICS code?
Tychon's NAICS: 32,325
How many employees does Tychon have?
Tychon has 1-10 employees
What industry does Tychon belong to?
Tychon is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Tychon competition?
Tychon top competitors include: Immunova Therapeutics, PhotonPharma, IN8bio, Affyimmune Therapeutics
What technology does Tychon use?
Some of the popular technologies that Tychon uses are: Squarespace Online Stores, Adobe Typekit, Vimeo, Amazon Route 53
How do I contact Tychon?
Tychon contact info: Phone number: (612) 200-1039 Website: www.tychonbio.com
What does Tychon do?

Tychon Biosciences is focused on advancing precision cancer immunotherapy through its innovative PAR-T technology, which trains patients' immune cells to target and eliminate cancer cells. Their flagship product, TYC201, is a protein-based drug designed to activate T-cells for cancer treatment, offering a safer, faster, and more cost-effective solu... tion. The therapy can be utilized as a standalone treatment or in conjunction with other therapies, making it suitable for both early and late-stage cancers. Tychon aims to enhance clinical adoption of T-cell based immunotherapy by addressing existing shortcomings in the field.Read More

What are Tychon social media links?
Tychon Linkedin page
Is Tychon a public company?
Tychon is private company therefore does not currently have an official ticker symbol
See more information about Tychon

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.